CA Drug Makers Point Finger At PBM, Issuers In Bid To Quash State Transparency Bill

The California drug lobby takes strong issue with drug pricing transparency legislation approved overwhelmingly by the state senate's health committee Wednesday, arguing the bill is counterproductive because it focuses on list prices and doesn't factor in the roles of pharmaceutical benefit mangers (PBMs) and insurer. State Sen. Ed Hernandez's (D) price transparency now heads to the California senate's appropriations committee. The bill -- sponsored by the California Labor Federation, Health Access California and UNITE HERE -- would require drug makers...